StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 5/3087% above fair value
$14.95−0.82 (-5.20%)

Close on Oct 30, 2026Market cap $408.18MP/E –Yield –

Earnings

Carlsmed's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$18.90M
+56.2% on a year earlier
EPS, Q2 FY2026
-$0.39
-$1.47 a year earlier
Latest guidance
Raised
Aug 5, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Carlsmed's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$18.90M+56.2%-$0.39Release
Q1 FY2026ended Mar 31, 2026May 5, 2026after the close$16.10M–-$0.32Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$15.20M–-$0.32Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$13.10M–-$0.40Release
Q2 FY2025ended Jun 30, 2025Aug 28, 2025after the close$12.10M–-$1.47Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Carlsmed's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueFY2026$74.00M – $78.00M$72.00M – $77.00MRaisedAug 5, 2026
RevenueFY2026$70.00M – $75.00M–NewFeb 25, 2026

Guidance history

Every forecast Carlsmed put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 5, 2026RevenueFY2026$74.00M – $78.00MRaised
May 5, 2026RevenueFY2026$72.00M – $77.00MNew
Feb 25, 2026RevenueFY2026$70.00M – $75.00MNew
Nov 6, 2025RevenueFY2025$49.00M – $50.00MNew
Aug 28, 2025RevenueFY2025$45.50M – $47.50MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Carlsmed filed with the SEC as exhibits to Form 8-K or 6-K